SAO · ABEV3.SA
Ambev S.A.
R$14.55-R$0.67 (-4.4%)
Ambev S.A.’s quoted price sits in the lower half of its reported 52-week range, 14.61% below the high.
Loading market information…
NASDAQ · AFYA · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Afya Limited’s quoted price sits in the lower half of its reported 52-week range, 37.07% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Afya Limited’s forward annual dividend is $0.66 per share, paid annual. The forward yield is 6.46% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Afya Limited’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of $0.38. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Afya Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Afya Limited, operating through its subsidiaries, is a prominent medical education provider in Brazil. The company delivers a comprehensive array of educational products and services primarily focused on the medical field, encompassing medical schools, preparatory courses for medical residency, advanced graduate studies, and various other programs tailored for medical professionals at all career stages. These offerings are available across its proprietary network and are also extended to external medical institutions. Beyond traditional education, Afya also offers digital health services through a subscription-based platform, accessible via a mobile app and website. This platform is specifically designed to assist healthcare practitioners and students with clinical decision-making by providing essential tools such as medical calculators, reference charts, up-to-date content, prescription guidance, clinical scoring systems, details on medical procedures, and laboratory examination information. While strong in medicine, Afya's educational portfolio spans a broader spectrum of health sciences, including dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine. Furthermore, the company extends its academic offerings beyond healthcare to include undergraduate and postgraduate degree programs in diverse subjects like business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. The company further enhances its educational ecosystem by providing specialized postgraduate medical programs, both printed and digital educational materials, an online medical learning platform, and hands-on medical training opportunities. As of December 31, 2021, Afya maintained an extensive network of 46 undergraduate and graduate medical school campuses, which included 30 operational undergraduate units and five approved units. This infrastructure supported a total capacity of 2,731 medical school seats, with 2,481 actively operating and an additional 278 seats approved for future use. Established in 1999, Afya Limited is headquartered in Nova Lima, Brazil.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:40 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 8, 2025 |
| $0.55+19.57% vs estimate |
| $160.33M-3.12% vs estimate |
| Q4 2024 | Mar 13, 2025 | $0.36+5.88% vs estimate | $136.95M-14.68% vs estimate |
|---|
| Q3 2024 | Nov 13, 2024 | $0.32-11.11% vs estimate | $153.95M+5.2% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
8 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $17.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
R$14.55-R$0.67 (-4.4%)
Ambev S.A.’s quoted price sits in the lower half of its reported 52-week range, 14.61% below the high.
R$16.44-R$0.31 (-1.85%)
MBRF Global Foods Company S.A.’s quoted price sits in the lower half of its reported 52-week range, 38.73% below the high.
$51.44+$0.86 (+1.7%)
John Wiley & Sons, Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.46% below the high.
R$7.81-R$0.07 (-0.89%)
Sendas Distribuidora S.A.’s quoted price sits in the lower half of its reported 52-week range, 45.12% below the high.
R$17.01+R$0.07 (+0.41%)
SLC Agrícola S.A.’s quoted price sits in the upper half of its reported 52-week range, 12.68% below the high.
R$3.55R$0.00 (0.0%)
Grupo Mateus S.A.’s quoted price sits in the lower half of its reported 52-week range, 46.54% below the high.
$33.80+$0.07 (+0.21%)
HealthStream, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.08% below the high.
R$15.66-R$0.27 (-1.69%)
M. Dias Branco S.A. Indústria e Comércio de Alimentos’s quoted price sits in the lower half of its reported 52-week range, 47.73% below the high.
